OVERVIEW

The Role of the Oncology Nurse in the Diagnosis and Treatment of Castleman Disease is organized by Paradigm Medical Communications LLC.

Release Date: November 30, 2021
Expiration Date: November 30, 2022

Target Audience:
This activity has been designed to address the educational needs of oncology nurses, including advanced practice nurses and registered nurses. It will also benefit PAs and other clinicians who manage patients with Castleman disease (CD).

Overview:
Castleman disease (CD) is a rare group of heterogeneous lymphoproliferative disorders, many of which have an unknown underlying etiology. Owing to its rarity and unknown etiology, many oncology nurses are unaware of this disease, despite it often being managed by hematology/oncology clinics. As a result, this webinar aims to educate oncology nurses on CD so they, in turn, are equipped to educate, advocate for, and support patients through the diagnosis and treatment process.

Learning Objectives:
After completing this activity, the participant should be better able to:
• Outline the signs and symptoms of CD as they relate to early diagnosis
• Describe US Food and Drug Administration-approved and guideline-recommended therapies for CD